FGF2 and Alzheimer disease: On the other hand, previous studies have suggested that the pro-inflammatory CNS status can resolve with AD progression such that pro-inflammatory factors decline and anti-inflammatory factors, including b-FGF, increase or normalize in association with senile plaques, neurofibrillary tangles, and neuropil threads in the later stages of AD [27,29].